Skip to main content Skip to search Skip to main navigation

German Bundestag Passes Cannabis Law

On 23 February, the German Bundestag approved the government's bill on the "controlled use of cannabis". The law allows adults to possess up to 50 grams of cannabis in private and up to 25 grams in public.

It allows the private cultivation of up to three plants and the distribution by cultivation associations under strict regulations. A maximum of 25 grams per day or 50 grams per month can be given to members. The distribution of cannabis to adolescents between the ages of 18 and 21 is permitted up to 30 grams per month with a limit of ten per cent THC content. Cannabis for consumption may only be distributed as hashish or marijuana of controlled quality and in pure form; medical cannabis remains subject to prescription.

Advertising for cannabis and cultivation associations will be banned, and a prevention campaign is planned. The reform will enter into force on 1 April 2024, while the regulations on cultivation associations will enter into force on 1 July 2024.

The German Bundesrat (Federal Council) will hold a final debate on the Cannabis Act on 22 March. It does not need to be approved there. However, the Federal Council could appeal to the Conciliation Committee and thus delay its implementation.


Source:

German Bundestag: Dokumente 2024


Meet the GMP Compliance Adviser

The GMP Compliance Adviser is the world's largest knowledge portal for quality management in the pharma business. 

The demo access is non-binding and ends automatically.

Test it now for free

You may also be Interested in the Following Articles:

EMA: New Q&A on Product Lifecycle Management (PLCM)

EMA: New Q&A on Product Lifecycle Management (PLCM)

The EMA has published new Questions & Answers on the use of the Product Lifecycle Management (PLCM) document, clarifying its role within the EU variations framework for post-approval quality changes.
Read more
EMA: New Q&A for Co-Processed Excipients

EMA: New Q&A for Co-Processed Excipients

The EMA has published new Questions & Answers on co-processed excipients (CoPEs) used in solid oral dosage forms, introducing a harmonised, risk-based regulatory approach applicable to human and veterinary medicines.

Read more
What is the Data Lifecycle?

What is the Data Lifecycle?

Here's the answer:
Read more
GMP Regulations Report 2025

GMP Regulations Report 2025

What do the regulatory developments mean for your professional environment? Which requirements have a direct impact on your day-to-day work, and where is there an urgent need for action? Our GMP Regulations Report 2025 provides a clear structure, practical explanations, and the most important regulatory developments of 2025 – concise, well-organized, and relevant.
Read more
EU: Parliament Approves Regulation Proposal on Critical Medicines

EU: Parliament Approves Regulation Proposal on Critical Medicines

The European Parliament has approved regulatory measures aimed at strengthening the availability and supply of critical medicines in the EU.
Read more
What is a gas?

What is a gas?

You can view the answer here:
Read more
Previous
Next